ArticleMolecular diversity2017

Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity.

Jinying Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.